PATENT CLAIM ANALYSIS

Application Number: 15760878
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-11
Patent Classification: ["424", "186100"]

Abstract:
Provided are polypeptides derived from the coronaviruses (CoVs) Spike protein (S) characterized by high affinity and specificity the S receptor and its neutralizing antibodies. Further provided are compositions and vaccines, and vaccine-based therapies targeting CoVs, and SARS and MERS viruses in particular.

Claim (Index 54):
The polypeptide according to  claim 53 , wherein said reconstituted SARS-CoV RBM is a mutated RBM having a K465I mutation, said RBM comprises residues 432STGNYNYKYRL 443  as denoted by SEQ ID NO: 5 and  460 FSPDGIPCTPCTPPALNCYWPLNDYGFYTT 486  as denoted by SEQ ID NO: 30 or any fragments or derivatives thereof, linked by said at least one linker that replaces the loop or any parts thereof.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 90.0
- Lexical Diversity: 1.35135
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15306617', '10997201', '14375083', '15553466', '14717760']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8113038901848807
- 35 USC 102 Novelty (BERT): 0.5512230487400759
- Combined Prediction Score: 0.7852958060404003
- Mean Citation Score: 451.928406
- Max Citation Score: 490.51212
- Similarity Product: 269.26938462600947

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test